← Back to Search

Learning in a Virtual Environment (LIVE) for Stroke (SUPPORT Trial)

Waitlist Available
Led By Jennifer Beauchamp, PhD, RN
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Screening 3 weeks
Treatment Varies
Follow Up post intervention (8 weeks form baseline)
Awards & highlights

SUPPORT Trial Summary

This trial is to test a new virtual reality intervention specifically for stroke survivors and caregivers that includes real-time education and social interaction. They want to see if it is feasible and acceptable to participants, and if it can be used to generate hypotheses for a larger trial to show treatment efficacy.

SUPPORT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post intervention (8 weeks from baseline)
This trial's timeline: 3 weeks for screening, Varies for treatment, and post intervention (8 weeks from baseline) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability as assessed by the number of VE Meetings attended
Acceptability as assessed by the number of VE objects manipulated
Feasibility as assessed by the number of participants enrolled in the study
+6 more
Secondary outcome measures
Change in ability to recover form stress as measured by the Brief Resilience Scale
Change in anxiety as assessed by the Generalized Anxiety Disorder-7 score
Change in caregiver burden as assessed by the Zarit Burden Interview (ZBI)
+7 more

SUPPORT Trial Design

1Treatment groups
Experimental Treatment
Group I: TreatmentExperimental Treatment1 Intervention
First Studied
Drug Approval Stage
How many patients have taken this drug
Learning in a Virtual Environment (LIVE)

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center, HoustonLead Sponsor
903 Previous Clinical Trials
320,955 Total Patients Enrolled
42 Trials studying Stroke
7,385 Patients Enrolled for Stroke
Jennifer Beauchamp, PhD, RNPrincipal InvestigatorThe University of Texas Health Science Center, Houston
1 Previous Clinical Trials
14 Total Patients Enrolled
1 Trials studying Stroke
14 Patients Enrolled for Stroke

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are there in this experiment?

"Indeed, the data posted on clinicaltrials.gov indicates that this research project is still actively recruiting participants. The study was first published on April 27th 2022 and underwent its most recent alteration on August 2nd of the same year. This trial has a vacancy for 30 patients at one site only."

Answered by AI

Are there any openings available to participate in this research?

"Clinicaltrials.gov attests that this clinical trial is actively enrolling participants, the first posting of which occurred on April 27th 2022 with a resultant edit made August 2nd 2022."

Answered by AI

What goals is this research endeavor seeking to accomplish?

"The primary result that will be measured 8 weeks after baseline is the number of times patients log in, which serves as a proxy for usability. Secondary objectives include assessing anxiety levels via the Generalized Anxiety Disorder-7 score, perceived social support with the Multidimensional Scale of Perceived Social Support (MSPSS), and instrumental aid through PROMIS Short Form v2.0."

Answered by AI

Who else is applying?

What state do they live in?
How old are they?
18 - 65
What site did they apply to?
The University of Texas Health Science Center at Houston
What portion of applicants met pre-screening criteria?
Met criteria

How responsive is this trial?

Most responsive sites:
  1. The University of Texas Health Science Center at Houston: < 24 hours
Average response time
  • < 1 Day
Typically responds via
Phone Call
~8 spots leftby Apr 2025